Quarterly Results

GUFIC BIOSCIENCES LTD.

NSE : GUFICBIOBSE : 509079ISIN CODE : INE742B01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE234.3012.2 (+5.49 %)
PREV CLOSE ( ) 222.10
OPEN PRICE ( ) 226.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9204
TODAY'S LOW / HIGH ( )225.80 235.40
52 WK LOW / HIGH ( )170.2 289.55
NSE232.8510.5 (+4.72 %)
PREV CLOSE( ) 222.35
OPEN PRICE ( ) 225.50
BID PRICE (QTY) 232.85 (3614)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 182882
TODAY'S LOW / HIGH( ) 225.50 235.50
52 WK LOW / HIGH ( )171.75 290
Quarters
Select year  
( in Million)
Particulars
Mar 2022
Dec 2021
Sep 2021
Jun 2021
Audited / UnAudited
Audited
UnAudited
Audited
UnAudited
Net Sales
1621.93
1720.65
1941.39
2507.58
Total Expenditure
1306.73
1393.47
1583.1
2051.1
PBIDT (Excl OI)
315.2
327.18
358.29
456.48
Other Income
0.41
15.3
3.05
12.28
Operating Profit
315.61
342.49
361.34
468.76
Interest
10.57
10.32
15.49
12.09
Exceptional Items
NA
NA
NA
NA
PBDT
305.04
332.17
345.85
456.67
Depreciation
43.27
44.84
41.97
41.26
Profit Before Tax
261.77
287.33
303.88
415.41
Tax
59.12
76.99
70.53
103.34
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
202.65
210.34
233.35
312.07
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
202.65
210.34
233.35
312.07
Equity Capital
96.94
96.95
96.94
96.95
Face Value (IN RS)
1
1
1
1
Reserves
Calculated EPS
2.09
2.16
2.40
3.21
Calculated EPS (Annualised)
8.36
8.67
9.62
12.87
No of Public Share Holdings
23768355
23768355
23768355
33802198
% of Public Share Holdings
24.52
24.52
24.52
34.87
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
19.43
19.01
18.45
18.20
PBIDTM%
19.45
19.90
18.61
18.69
PBDTM%
18.80
19.30
17.81
18.21
PBTM%
16.13
16.69
15.65
16.56
PATM%
12.49
12.22
12.01
12.44
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)